HANGZHOU, China, March 3, 2025 /PRNewswire/ — METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22, 2025. In…
